Oncology Meeting Innovations’ (OMI’s) Expert Forum on Chronic Lymphocytic Leukemia fosters debates on the rapidly expanding information on molecular diagnostics, genomic analysis, new molecular targets, and the evolution of care over the next five years of chronic lymphocytic leukemia treatment. There will be a focus on the current treatment of chronic lymphocytic leukemia and the integration of novel B-cell signaling inhibitors and other emerging therapeutic targets into the treatment paradigm. The meeting will also explore the frontline landscape, management of toxicities, assessment of response and progression, minimal residual disease, and other practical issues. The Expert Forum assembles a distinguished group of preclinical and translational experts for an open discussion on new data.
Venue: Hilton Anatole
July 27-28, 2018
Dallas, Texas 75207, United States